Status:
COMPLETED
An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to register the occurrence of cardiovascular disease among type 2 diabetes (T2DM) patients across five selected countries in Europe. Participants will be asked to give info...
Eligibility Criteria
Inclusion
- Signed informed consent obtained before any study-related activities (study-related activities are any procedures related to recording of data according to protocol)
- Male or female, age greater than or equal to 18 years at the time of signing informed consent
- Diagnosed with type 2 diabetes mellitus greater than or equal to 180 days prior to the day of signing the informed consent
Exclusion
- Previous participation in this study. Participation is defined as having given informed consent in this study
- Diagnosed with Type 1 diabetes
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
- Patients with known congenital heart disease/malformation
Key Trial Info
Start Date :
December 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2019
Estimated Enrollment :
2275 Patients enrolled
Trial Details
Trial ID
NCT03786406
Start Date
December 3 2018
End Date
May 31 2019
Last Update
June 22 2023
Active Locations (41)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Benátky nad Jizerou, Czechia, 29471
2
Novo Nordisk Investigational Site
Boskovice, Czechia, 68001
3
Novo Nordisk Investigational Site
Brandýs nad Labem, Czechia, 25001
4
Novo Nordisk Investigational Site
Břeclav, Czechia, 69002